搜尋結果
2023
Chu, C. Y. ,
Lin, C. Y. ,
Lin, C. C. ,
Li, C. F. ,
Wu, S. Y. ,
Tsai, J. S. ,
Yang, S. C. ,
Chen, C. W. ,
Lin, C. Y. ,
Chang, C. C. ,
Yen, Y. T. ,
Tseng, Y. L. ,
Su, P. L. &
Su, W. C. ,
2023 12月 ,
於: Scientific reports. 13 ,
1 , 3943.
研究成果: Article › 同行評審
ErbB Receptors
100%
Protein-Tyrosine Kinases
95%
Non-Small Cell Lung Carcinoma
93%
Ligands
74%
Gefitinib
32%
Cho, W. H. ,
Chuang, S. S. ,
Chu, C. Y. ,
Fong, Y. &
Kuo, S. C. ,
2023 9月 ,
於: Acta Ophthalmologica. 101 ,
6 ,
p. 705-707 3 p. 研究成果: Article › 同行評審
2022
Su, P. L. ,
Chen, J. Y. ,
Chu, C. Y. ,
Chen, Y. L. ,
Chen, W. L. ,
Lin, K. Y. ,
Ho, C. L. ,
Tsai, J. S. ,
Yang, S. C. ,
Chen, C. W. ,
Wu, Y. L. ,
Tseng, Y. L. ,
Chang, C. C. ,
Yen, Y. T. ,
Lin, C. Y. ,
Lin, C. C. &
Su, W. C. ,
2022 12月 ,
於: Scientific reports. 12 ,
1 , 3319.
研究成果: Article › 同行評審
Immunotherapy
100%
Lung Neoplasms
89%
Drug Therapy
66%
Mutation
63%
Neoadjuvant Therapy
39%
2021
Lin, C. Y. ,
Chang, C. C. ,
Chu, C. Y. ,
Huang, L. T. ,
Chung, T. J. ,
Liu, Y. S. &
Yen, Y. T. ,
2021 5月 19 ,
於: Frontiers in Medicine. 8 , 650381.
研究成果: Article › 同行評審
Needle Biopsy
100%
Tomography
62%
Lung
20%
Precision Medicine
14%
Diagnostic Imaging
13%
Liu, I. T. ,
Yen, C. S. ,
Wang, W. L. ,
Tsai, H. W. ,
Chu, C. Y. ,
Chang, M. Y. ,
Hou, Y. F. &
Yen, C. J. ,
2021 11月 1 ,
於: Cancers. 13 ,
21 , 5323.
研究成果: Article › 同行評審
Artificial Intelligence
100%
Hepatocellular Carcinoma
60%
Fluorescence Microscopy
37%
Area Under Curve
20%
Sensitivity and Specificity
18%
Yen, C. C. ,
Huang, W. L. ,
Li, S. S. ,
Chen, Y. P. ,
Tseng, Y. L. ,
Yen, Y. T. ,
Chu, C. Y. ,
Hsu, Y. T. &
Chen, T. Y. ,
2021 12月 13 ,
於: Frontiers in Medicine. 8 , 759914.
研究成果: Article › 同行評審
Thymoma
81%
Hematologic Diseases
78%
Systematic Reviews
49%
Muscle Weakness
39%
Immunosuppressive Agents
18%
Wu, C. H. ,
Su, P. L. ,
Hsu, C. W. ,
Chu, C. Y. &
Lin, C. C. ,
2021 11月 ,
於: Thoracic Cancer. 12 ,
22 ,
p. 3068-3071 4 p. 研究成果: Article › 同行評審
Crizotinib
100%
Non-Small Cell Lung Carcinoma
61%
Protein-Tyrosine Kinases
31%
Biopsy
21%
Receptor Protein-Tyrosine Kinases
18%
2020
Chang, C. C. ,
Lin, C. Y. ,
Chu, C. Y. ,
Hsiung, Y. C. ,
Chuang, M. T. ,
Tseng, Y. L. &
Yen, Y. T. ,
2020 10月 7 ,
於: Cancer Imaging. 20 ,
1 ,
p. 71 1 p. 研究成果: Article › 同行評審
Thymic epithelial tumor
100%
Thymoma
50%
Lymphocytes
43%
B-Lymphocyte Subsets
13%
Nonparametric Statistics
10%
2019
Yen, C. J. ,
Tsou, H. H. ,
Hsieh, C. Y. ,
Chu, C. Y. ,
Chiu, C. F. ,
Chen, C. C. ,
Tsao, C. J. ,
Tsai, K. Y. ,
Tsai, S. T. ,
Chang, J. Y. &
Chang, K. Y. ,
2019 6月 ,
於: Head and Neck. 41 ,
6 ,
p. 1703-1712 10 p. 研究成果: Article › 同行評審
TP protocol
100%
Cetuximab
88%
Neoadjuvant Therapy
81%
Squamous Cell Carcinoma
59%
Clinical Trials
46%
2018
Wei, Y. F. ,
Chu, C. Y. ,
Chang, C. C. ,
Lin, S. H. ,
Su, W. C. ,
Tseng, Y. L. ,
Lin, C. C. &
Yen, Y. T. ,
2018 11月 ,
於: Lung Cancer. 125 ,
p. 35-42 8 p. 研究成果: Article › 同行評審
Thymoma
100%
Survival
45%
Clone Cells
24%
Histology
16%
Multivariate Analysis
14%